254 related articles for article (PubMed ID: 25733852)
1. The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers.
Qian J; Hassanein M; Hoeksema MD; Harris BK; Zou Y; Chen H; Lu P; Eisenberg R; Wang J; Espinosa A; Ji X; Harris FT; Rahman SM; Massion PP
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3469-74. PubMed ID: 25733852
[TBL] [Abstract][Full Text] [Related]
2. Circ_0000079 Decoys the RNA-Binding Protein FXR1 to Interrupt Formation of the FXR1/PRCKI Complex and Decline Their Mediated Cell Invasion and Drug Resistance in NSCLC.
Chen C; Zhang M; Zhang Y
Cell Transplant; 2020; 29():963689720961070. PubMed ID: 32951448
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma.
Liu Y; Yin N; Wang X; Khoor A; Sambandam V; Ghosh AB; Fields ZA; Murray NR; Justilien V; Fields AP
Cell Rep; 2020 Jan; 30(3):771-782.e6. PubMed ID: 31968252
[TBL] [Abstract][Full Text] [Related]
4. Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung.
Comtesse N; Keller A; Diesinger I; Bauer C; Kayser K; Huwer H; Lenhof HP; Meese E
Int J Cancer; 2007 Jun; 120(12):2538-44. PubMed ID: 17290396
[TBL] [Abstract][Full Text] [Related]
5. Recurrent copy number gains drive PKCĪ¹ expression and PKCĪ¹-dependent oncogenic signaling in human cancers.
Liu Y; Justilien V; Fields AP; Murray NR
Adv Biol Regul; 2020 Dec; 78():100754. PubMed ID: 32992230
[TBL] [Abstract][Full Text] [Related]
6. Global gene expression profiling reveals a suppressed immune response pathway associated with 3q amplification in squamous carcinoma of the lung.
Qian J; Zou Y; Wang J; Zhang B; Massion PP
Genom Data; 2015 Sep; 5():272-4. PubMed ID: 26484266
[TBL] [Abstract][Full Text] [Related]
7. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
Liu M; Zhou K; Huang Y; Cao Y
J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
[TBL] [Abstract][Full Text] [Related]
8. Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers.
Hagerstrand D; Tong A; Schumacher SE; Ilic N; Shen RR; Cheung HW; Vazquez F; Shrestha Y; Kim SY; Giacomelli AO; Rosenbluh J; Schinzel AC; Spardy NA; Barbie DA; Mermel CH; Weir BA; Garraway LA; Tamayo P; Mesirov JP; Beroukhim R; Hahn WC
Cancer Discov; 2013 Sep; 3(9):1044-57. PubMed ID: 23764425
[TBL] [Abstract][Full Text] [Related]
9. Integrative genomics analysis identifies candidate drivers at 3q26-29 amplicon in squamous cell carcinoma of the lung.
Wang J; Qian J; Hoeksema MD; Zou Y; Espinosa AV; Rahman SM; Zhang B; Massion PP
Clin Cancer Res; 2013 Oct; 19(20):5580-90. PubMed ID: 23908357
[TBL] [Abstract][Full Text] [Related]
10. The RNA-binding protein FXR1 modulates prostate cancer progression by regulating FBXO4.
Cao H; Gao R; Yu C; Chen L; Feng Y
Funct Integr Genomics; 2019 May; 19(3):487-496. PubMed ID: 30746571
[TBL] [Abstract][Full Text] [Related]
11. RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site.
George J; Li Y; Kadamberi IP; Parashar D; Tsaih SW; Gupta P; Geethadevi A; Chen C; Ghosh C; Sun Y; Mittal S; Ramchandran R; Rui H; Lopez-Berestein G; Rodriguez-Aguayo C; Leone G; Rader JS; Sood AK; Dey M; Pradeep S; Chaluvally-Raghavan P
Cell Rep; 2021 Nov; 37(5):109934. PubMed ID: 34731628
[TBL] [Abstract][Full Text] [Related]
12. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation.
Justilien V; Fields AP
Oncogene; 2009 Oct; 28(41):3597-607. PubMed ID: 19617897
[TBL] [Abstract][Full Text] [Related]
13. Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma.
Qie S; Majumder M; Mackiewicz K; Howley BV; Peterson YK; Howe PH; Palanisamy V; Diehl JA
Nat Commun; 2017 Nov; 8(1):1534. PubMed ID: 29142209
[TBL] [Abstract][Full Text] [Related]
14. FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA.
Deng M; Wang N; Li Z; Chen R; Duan J; Peng Y; Wu Z; Zhang Z; Jiang L; Zheng X; Xie D; Wei W; Liu Z; Zhou F
Cell Death Dis; 2022 Feb; 13(2):170. PubMed ID: 35194031
[TBL] [Abstract][Full Text] [Related]
15. 3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study.
Pelosi G; Del Curto B; Trubia M; Nicholson AG; Manzotti M; Veronesi G; Spaggiari L; Maisonneuve P; Pasini F; Terzi A; Iannucci A; Viale G
Clin Cancer Res; 2007 Apr; 13(7):1995-2004. PubMed ID: 17404079
[TBL] [Abstract][Full Text] [Related]
16. Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma.
Yang YL; Chu JY; Luo ML; Wu YP; Zhang Y; Feng YB; Shi ZZ; Xu X; Han YL; Cai Y; Dong JT; Zhan QM; Wu M; Wang MR
Genes Chromosomes Cancer; 2008 Feb; 47(2):127-36. PubMed ID: 17990328
[TBL] [Abstract][Full Text] [Related]
17. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB
Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414
[TBL] [Abstract][Full Text] [Related]
18. The oncogenic role of PKCiota gene amplification and overexpression in Chinese non-small cell lung cancer.
Luo Q; Tang L; Lin H; Huang J; Zhang T; Liu Y; Wang J; Zhan P; Yin X; Su X; Ji Q; Yu D; Xu L
Lung Cancer; 2014 May; 84(2):190-5. PubMed ID: 24636699
[TBL] [Abstract][Full Text] [Related]
19. The multifaceted role of Fragile X-Related Protein 1 (FXR1) in cellular processes: an updated review on cancer and clinical applications.
Khan FA; Fang N; Zhang W; Ji S
Cell Death Dis; 2024 Jan; 15(1):72. PubMed ID: 38238286
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas.
Sarkaria I; O-charoenrat P; Talbot SG; Reddy PG; Ngai I; Maghami E; Patel KN; Lee B; Yonekawa Y; Dudas M; Kaufman A; Ryan R; Ghossein R; Rao PH; Stoffel A; Ramanathan Y; Singh B
Cancer Res; 2006 Oct; 66(19):9437-44. PubMed ID: 17018598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
